Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury-Reference-Cited by-同舟云学术

Phosphodiesterase 4 inhibition reduces lung fibrosis following targeted type II alveolar epithelial cell injury

Published:2018-06 Issue:12 Volume:6 Page:e13753
ISSN:2051-817X
Container-title:Physiological Reports
language:en
Short-container-title:Physiol Rep

Author:

Sisson Thomas H.¹,Christensen Paul J.²,Muraki Yo³,Dils Anthony J.¹,Chibucos Lauren¹,Subbotina Natalya¹,Tohyama Kimio³,Horowitz Jeffrey C.¹,Matsuo Takanori³,Bailie Marc⁴,Nikam Sham³,Hazama Masatoshi³

Affiliation:

1. Pulmonary and Critical Care Division; Department of Internal Medicine; University of Michigan Medical Center; Ann Arbor Michigan

2. Division of Pulmonary & Critical Care Medicine; Department of Internal Medicine; William Beaumont Medical Center; Troy Michigan

3. Takeda Pharmaceutical Company Limited; Fujisawa Japan

4. In Vivo Facility; Department of Pharmacology and Toxicology; Michigan State University; East Lansing Michigan

Funder

Takeda Pharmaceuticals

National Institutes of Health

Publisher

Wiley

Subject

Physiology (medical),Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.14814/phy2.13753/fullpdf

Reference47 articles.

1. Idiopathic pulmonary fibrosis: from epithelial injury to biomarkers-insights from the bench side;Borensztajn;Respiration,2013

2. Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis;Chaudhary;Eur. Respir. J.,2007

3. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells;Chu;Pediatr. Allergy Immunol.,2010

4. Therapeutic administration of inhaled INS1009, a treprostinil prodrug formulation, inhibits bleomycin-induced pulmonary fibrosis in rats;Corboz;Pulm. Pharmacol. Ther.,2018

5. Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury;Cortijo;Br. J. Pharmacol.,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological mechanisms and novel drug targets in fibrotic interstitial lung disease;Inflammation and Regeneration;2024-07-19

2. Exploring therapeutic targets for molecular therapy of idiopathic pulmonary fibrosis;Science Progress;2024-04

3. Single cell-resolved study of advanced murine MASH reveals a homeostatic pericyte signaling module;Journal of Hepatology;2023-11

4. 3D-SMGE: a pipeline for scaffold-based molecular generation and evaluation;Briefings in Bioinformatics;2023-09-22

5. Beyond epithelial damage: vascular and endothelial contributions to idiopathic pulmonary fibrosis;Journal of Clinical Investigation;2023-09-15